Research2Guidance January 29, 2024
GLP-1 companion apps are a win-win for pharma, health plans, behavior change app publishers and patients. Major weight loss app publishers have added GLP-1 specific programs to their portfolios. National health systems and health plans started to make companion solutions mandatory. Other companion solution providers should monitor progress of these solutions closely and adopt.
GLP-1 (Glucagon-like peptide-1) apps are designed to support individuals who are prescribed GLP-1 receptor agonists, a class of medications commonly used to treat type 2 diabetes. These apps typically offer features that help users manage their diabetes, monitor their GLP-1 therapy, and make lifestyle choices that support overall health.
Recently GLP-1 drugs became the weight loss drug for people in mainly western countries to efficiently lose...
Today's Sponsors
Today's Sponsor